Show simple item record

dc.contributor.authorEgan, A. M.
dc.contributor.authorMcPhillips, D.
dc.contributor.authorSarkar, S.
dc.contributor.authorBreen, D. P.
dc.date.accessioned2018-09-20T16:07:02Z
dc.date.available2018-09-20T16:07:02Z
dc.date.issued2013-12-24
dc.identifier.citationEgan, A. M. McPhillips, D.; Sarkar, S.; Breen, D. P. (2013). Malignant pleural effusion. QJM 107 (3), 179-184
dc.identifier.issn1460-2725,1460-2393
dc.identifier.urihttp://hdl.handle.net/10379/11322
dc.description.abstractMalignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management should be prompt and care plans should be individualized and involve a multidisciplinary team of healthcare professionals. This article reviews the pathophysiology of MPE along with available investigations and management strategies for these patients.
dc.publisherOxford University Press (OUP)
dc.relation.ispartofQJM
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectdisease guideline 2010
dc.subjectrandomized controlled-trial
dc.subjectthoracic ultrasound
dc.subjectcytopathologic diagnoses
dc.subjectchemical pleurodesis
dc.subjecttalc pleurodesis
dc.subjectneedle-biopsy
dc.subjectmanagement
dc.subjectspecialist
dc.subjectcatheter
dc.titleMalignant pleural effusion
dc.typeArticle
dc.identifier.doi10.1093/qjmed/hct245
dc.local.publishedsourcehttps://academic.oup.com/qjmed/article-pdf/107/3/179/4468129/hct245.pdf
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland